Has John McCallin, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,083 in general payments to John McCallin, MD across 104 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John McCallin, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John McCallin, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John McCallin, MD

Physical Medicine & Rehabilitation · Cleveland, OHNPI 1609038397

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.7% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Boston Scientific at 50.8% of the total. Among physical medicine & rehabilitation clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,083in general payments, 2019–2025

Across 104 payments — averaging $77.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$4K
Nevro Corp.$867
Abbott$706
SPR Therapeutics, Inc$510
Saluda Medical Americas, Inc.$471
MML US, Inc.$412
plus $1K from 8 others

What the payments were for

Travel & lodging$2693%
Food & beverage$7,81497%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	48	$4,107
Nevro Corp.	9	$867
Abbott	11	$706
SPR Therapeutics, Inc	7	$510
Saluda Medical Americas, Inc.	4	$471
MML US, Inc.	4	$412
Vertos Medical, Inc.	2	$248
Globus Medical	4	$212
Averitas Pharma Inc.	7	$182
Medtronic	2	$138
Relievant Medsystems, Inc.	1	$123
GRT US Holding, Inc.	3	$78
Nalu Medical, Inc.	1	$16
Collegium Pharmaceutical, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

WaveWriter Alpha Prime 16$1,911
GENERAL PAIN MANAGEMENT$708
Senza$448
SPECTRA WAVEWRITER$441
ReActiv8$357
SPRINT PNS System$356
Omnia$284
Evoke$277
ETERNA$274
SUPERION$261
mild Device Kit$248
Evoke SCS$175
PROCLAIM$145
Senza Spinal Cord Stimulation System$138
WAVEWRITER ALPHA$123
Intracept$123
SYNCHROMEDII$123
Axium INS DRG IPG$109

How this compares

$8,083 in reported general payments places this provider in the 90th percentile of 332 physical medicine & rehabilitation providers in Ohio.

See all physical medicine & rehabilitation providers in Ohio →

Medicare billing

Part B allowed, 2024

$73,621

Medicare patients

250

Services billed

1,981

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	895	$13,758
Duloxetine Hcl	523	$5,551
Buprenorphine	17	$3,639
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	103	$1,983
Tizanidine Hcl	167	$1,875
Pregabalin	65	$1,624
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	47	$1,091
Topiramate	83	$1,011
Methocarbamol	48	$861
Nortriptyline Hcl	57	$564
Amitriptyline Hcl	46	$507
Celecoxib	18	$442
Tramadol Hcl	41	$269
Meloxicam	76	$218
Oxycodone Hcl	17	$181

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Cleveland

Francois BethouxCleveland$39K
Maria GrabnarCleveland$13K
John ChaeCleveland$10K
Prudencio BalagtasCleveland$8K
Marzena BuzanowskaCleveland$6K
Tariq NiaziCleveland$2K
Santhosh ThomasCleveland$2K
Michael BariaLewis Center$175K
Kathryn MosherAkron$121K
Marc OrlandoCincinnati$114K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →